Inbuilt body clocks link breast stiffness to cancer risks
University of Manchester biologists have discovered that breast tissues have twenty four hour body clocks, and that several hundred genes are regulated in a daily cycle (University of Manchester, 2017). The discovery by Dr Qing-Jun Meng and Professor Charles Streuli, may offer the first evidence of a link between breast biology, including breast cancer risks, … Continue reading Inbuilt body clocks link breast stiffness to cancer risks
Research agreement could prevent cervical cancer in millions of women
The University of Manchester has, through its Innovation Company (UMI3), signed a licensing and research agreement with Douglas Pharmaceuticals that could save the lives of millions of women around the world suffering from early stage cervical cancer (University of Manchester, 2017). The deal initially sees New Zealand-based Douglas Pharmaceuticals sponsor research at Manchester University to … Continue reading Research agreement could prevent cervical cancer in millions of women
New drug cocktail unlocks potential of new Leukaemia treatment
A new combination of drugs tested by University of Manchester scientists has significantly enhanced the survival of laboratory mice with lymphoma (University of Manchester, 2017). According to the team, the effect of Obinutuzumab, a first-line treatment for non-Hodgkin lymphoma and leukaemia, is significantly enhanced when combined with drugs that stimulate the immune system. The research … Continue reading New drug cocktail unlocks potential of new Leukaemia treatment
Heart attack risk in rheumatoid arthritis patients almost halved by biologic drugs
A biologic drug which treats rheumatoid arthritis has been shown to reduce the risk of heart attacks in arthritis patients by up to 40% (University of Manchester, 2017). Patients with rheumatoid arthritis have a 60% higher risk of heart attacks than the general public, which is thought to be linked to the inflammation caused by … Continue reading Heart attack risk in rheumatoid arthritis patients almost halved by biologic drugs
Manchester Molecular Pathology Innovation Centre announces strategic collaboration with Singulex
The University of Manchester has announced a strategic collaboration with US company Singulex, a leader in the use of single molecule counting technology as a diagnostic tool (The University of Manchester, 2016). Singulex has installed its SMCTM powered Sgx ClarityTM System in the Manchester Molecular Pathology Innovation Centre (MMPathIC) labs as part of its ongoing … Continue reading Manchester Molecular Pathology Innovation Centre announces strategic collaboration with Singulex
Genetics links sleep disturbance with restless leg syndrome, schizophrenia and obesity
A team of American and British scientists have discovered genetic connections between sleep disturbance and a range of medical disorders including obesity (The University of Manchester, 2016). Lead author Dr Jacqueline Lane, postdoctoral fellow at Massachusetts General Hospital (MGH) and joint senior authors Richa Saxena, Assistant Professor of Anaesthesia at the MGH and Harvard Medical … Continue reading Genetics links sleep disturbance with restless leg syndrome, schizophrenia and obesity
